We are live on ! Find out more
GCVRZ

Sanofi Contingent Value Rights
GCVRZ

Delisted

GCVRZ was delisted on the 3rd of March, 2020.

Back to rankings

146 hedge funds and large institutions have $324M invested in Sanofi Contingent Value Rights in 2013 Q2 according to their latest regulatory filings, with 146 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
146
Holders Change
+146
Holders Change %
–
% of All Funds
4.77%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
% of All Funds
0.16%
New
146
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
JGC
51
J. Goldman & Co
New York
$494K +$457K +260,000 New
Susquehanna International Group
52
Susquehanna International Group
Pennsylvania
$423K +$391K +222,786 New
WCM
53
Waterstone Capital Management
Minnesota
$328K +$303K +172,591 New
ACM
54
American Capital Management
New York
$288K +$266K +151,420 New
EEG
55
E.E. Geduld
$285K +$264K +150,000 New
LOAMU
56
Lombard Odier Asset Management (USA)
New York
$285K +$264K +150,000 New
Goldman Sachs
57
Goldman Sachs
New York
$251K +$232K +132,307 New
KAM
58
Knightsbridge Asset Management
California
$224K +$207K +117,700 New
BCM
59
Basso Capital Management
Connecticut
$212K +$193K +110,000 New
ZIG
60
Zuckerman Investment Group
Illinois
$201K +$186K +105,973 New
TCM
61
Tekla Capital Management
Massachusetts
$200K +$182K +103,665 New
Neuberger Berman Group
62
Neuberger Berman Group
New York
$188K +$174K +98,920 New
DMK
63
David M. Knott
$175K +$162K +92,000 New
U
64
UBS
Switzerland
$173K +$160K +90,921 New
CCA
65
Catalyst Capital Advisors
New York
$154K +$141K +80,000 New
CAS
66
CTC Alternative Strategies
Illinois
$144K +$133K +75,900 New
WMSA
67
Weiss Multi-Strategy Advisers
New York
$143K +$132K +75,000 New
Wells Fargo
68
Wells Fargo
California
$136K +$126K +71,530 New
IRF
69
IBM Retirement Fund
New York
$134K +$122K +69,395 New
ACA
70
Anchor Capital Advisors
Massachusetts
$119K +$110K +62,835 New
DAM
71
Deltec Asset Management
New York
$112K +$104K +59,025 New
Brown Advisory
72
Brown Advisory
Maryland
$98K +$91.1K +51,844 New
Korea Investment Corp
73
Korea Investment Corp
South Korea
$96K +$87.3K +49,700 New
TPM
74
T2 Partners Management
New York
$95K +$87.8K +50,000 New
BNP Paribas Financial Markets
75
BNP Paribas Financial Markets
France
$93K +$86K +48,963 New
1 2
3
4 5

GCVRZ Hedge Fund Activity: Q2 2013 in Review

146 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q2 2013, worth a combined $324M.

Buyers outnumbered sellers: 146 funds opened new GCVRZ positions and 0 closed out — a net gain of 146 holders — while 0 added to existing stakes and 0 trimmed.

  • 146 institutional investors held Sanofi Contingent Value Rights (GCVRZ) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $324M of Sanofi Contingent Value Rights stock for Q2 2013.
  • 146 funds opened new Sanofi Contingent Value Rights positions in Q2 2013 and 0 closed out, a net change of +146 holders.

Based on aggregated 13F filings for Q2 2013.